In ovarian cancer models, different miRNA sites have been shown to downregulate the expression of CSF1, while binding of glyceraldehyde‐3‐phosphate dehydrogenase to the CSF1‐ARE regulates the stability and degradation of CSF1 mRNA.28, 29, 30. The gene discussed is CSF1; the disease is ovarian carcinoma.